| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/25/2004 | WO2002017899A3 Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration |
| 03/25/2004 | WO2002002095B1 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 03/25/2004 | US20040060077 Using dietary restriction to lower serum insulin levels and function as tool in treatment and prevention of alzheimer's diseases |
| 03/25/2004 | US20040060071 PVR set-up over the internet |
| 03/25/2004 | US20040059408 Polymer compositions for intraluminal stent |
| 03/25/2004 | US20040059383 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 03/25/2004 | US20040059241 Method for classifying and treating physiologic brain imbalances using quantitative EGG |
| 03/25/2004 | US20040059190 Method of colpoplasty |
| 03/25/2004 | US20040059144 Aspirin-triggered lipid mediators |
| 03/25/2004 | US20040059142 Combining a crude arachidonic acid(ARA) a polyunsaturated fatty acids (PUFAs) containing oil with a crude DHA OR EPA(docosahexaenoic acid or eicosapentaenoic acid) containing oil, purifying to produce purified ARA, DHA or EPA |
| 03/25/2004 | US20040059140 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile |
| 03/25/2004 | US20040059136 7-carboxy-flavone derivatives preparation method and therapeutic use |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040059130 Benz(f)indole compounds useful for Inflammatory Diseases |
| 03/25/2004 | US20040059120 Such as (5R)-3-(3-fluoro-4-(2-oxo-1,3-oxazolan-3-yl)phenyl)-5-hydroxymethyl-1,3 -oxazolan-2-one |
| 03/25/2004 | US20040059118 Which inhibit thrombin |
| 03/25/2004 | US20040059117 Process for producing carbostyril derivatives |
| 03/25/2004 | US20040059115 Such as ((benzylsulfonylamino)methyl)-phosphonic acid mono-(4-nitrophenyl)ester sodium salt; for treating bacterial antibiotic resistance |
| 03/25/2004 | US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 03/25/2004 | US20040059110 Such as N,N'-bis(2-hydroxybenzyl)-L-cystine |
| 03/25/2004 | US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics |
| 03/25/2004 | US20040059107 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; pharmaceutical formulations, improved cell and organ culture media, cryopreservation media, antiaging, chemoprotective and radioprotective uses |
| 03/25/2004 | US20040059104 Nucleotide mimics and their prodrugs |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040059066 Injections for endoscopy |
| 03/25/2004 | US20040059065 Polymer containing amino or imino groups crosslinked by a compound having a vinyl group that reacts by michael addition reaction or a carboxy ester group; medicinal phosphorus adsorbers |
| 03/25/2004 | US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use |
| 03/25/2004 | US20040059003 NMDA receptor antagonist formulation with reduced neurotoxicity |
| 03/25/2004 | US20040059002 Sustained release delivery of amphetamine salts |
| 03/25/2004 | US20040059001 Extended release pharmaceutical composition containing metformin |
| 03/25/2004 | US20040059000 Therapeutic agents and corresponding treatments |
| 03/25/2004 | US20040058999 Aids therapy; using xanaldial, xenalamine, xenalic acid |
| 03/25/2004 | US20040058997 Moderating dopaminergic factor; administering anticoagulant |
| 03/25/2004 | US20040058996 Usage of vinegar acid for the treatment of dermomycosis |
| 03/25/2004 | US20040058995 Agent for improving bone metabolism |
| 03/25/2004 | US20040058994 Local prevention or amelioration of pain from surgically closed wounds |
| 03/25/2004 | US20040058993 Prevention, therapy of liver disorders; using aminomethanesulfonic acid |
| 03/25/2004 | US20040058991 Anticonvulsants; central nervous system disorders |
| 03/25/2004 | US20040058990 Thrombopoietin mimetics |
| 03/25/2004 | US20040058989 Solid dosage form; antidepressant |
| 03/25/2004 | US20040058988 Fatty acid synthase inhibitors |
| 03/25/2004 | US20040058987 Hypotensive agents; oxidation resistance, nitrogen scavenger; anticancer agents; antiischemic agents |
| 03/25/2004 | US20040058986 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 03/25/2004 | US20040058984 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 03/25/2004 | US20040058983 Plan-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 03/25/2004 | US20040058982 Pharmaceutical compositions |
| 03/25/2004 | US20040058981 Administering free radical generators such as artemisinim, arteflene |
| 03/25/2004 | US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 03/25/2004 | US20040058978 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs |
| 03/25/2004 | US20040058976 Ophthalmic compositions for treating ocular hypertension |
| 03/25/2004 | US20040058975 Using prostaglandin antagonist and cyclooxygenase inhibitor; contraceptive; delay releasing oocytes |
| 03/25/2004 | US20040058974 Administering posaconazole by mouth |
| 03/25/2004 | US20040058973 Therapy for sleep disorders; administering orally |
| 03/25/2004 | US20040058972 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 03/25/2004 | US20040058971 Substituted dipeptides as growth hormone secretagogues |
| 03/25/2004 | US20040058970 Alzheimer's disease |
| 03/25/2004 | US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents |
| 03/25/2004 | US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 03/25/2004 | US20040058967 Crystalline organic acid salt of amlodipine |
| 03/25/2004 | US20040058966 Method for reducing or eliminating smoking |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058963 Cardiovascular disorders; hypotensive agents; antiallergens; antihistamines; antiarthritic agents; skin disorders |
| 03/25/2004 | US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases |
| 03/25/2004 | US20040058958 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 03/25/2004 | US20040058952 Urease inhibitors |
| 03/25/2004 | US20040058950 Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
| 03/25/2004 | US20040058949 Novel salt and polymorphs of desloratadine hemifumarate |
| 03/25/2004 | US20040058948 Transcripase inhibitor; viricides |
| 03/25/2004 | US20040058947 Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder |
| 03/25/2004 | US20040058945 N-type calcium channel antagonists for the treatment of pain |
| 03/25/2004 | US20040058943 Reducing exercise tolerance depression; using phenylethenesulfonamide compound |
| 03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 03/25/2004 | US20040058940 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/25/2004 | US20040058939 Derivatives of variolin b |
| 03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
| 03/25/2004 | US20040058936 Dietetics, sexual disorders, antidiabetic agents |
| 03/25/2004 | US20040058935 Crystals; storage stability; psychological disorders |
| 03/25/2004 | US20040058934 Heterocyclic compounds |
| 03/25/2004 | US20040058933 Aryl carbamate derivatives, preperation and use thereof |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |
| 03/25/2004 | US20040058929 Phosphodiesterase inhibitors; sexual disorders; side effect reduction; using sildenafil |
| 03/25/2004 | US20040058927 Tackykinin antagonist |
| 03/25/2004 | US20040058926 Vision defects; administering celecoxib |
| 03/25/2004 | US20040058925 Method of treating fibromyalgia and other somatoform disorders |
| 03/25/2004 | US20040058924 Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
| 03/25/2004 | US20040058923 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 03/25/2004 | US20040058922 Tyrosine inhibitor; immunosuppressants; antiarthritic agents; autoimmune diseases; antiproliferative agent |
| 03/25/2004 | US20040058921 Psychological disorders; antidepressants; sexual disorders ; eating disorders |
| 03/25/2004 | US20040058920 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 03/25/2004 | US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 03/25/2004 | US20040058915 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/25/2004 | US20040058914 Combination drugs |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | US20040058912 Psychological disorders; eating disorders; dietetics |
| 03/25/2004 | US20040058911 Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 03/25/2004 | US20040058910 Drug abuse, alcoholism, tobacco |
| 03/25/2004 | US20040058909 Method of treatment |
| 03/25/2004 | US20040058908 Mixture of bile acid transport inhibitor, cholesteryl ester transport protein inhibitor, fibric acid, nicotinic acid, microsomal triglyceride transfer protein inhibitor and sterols |
| 03/25/2004 | US20040058907 Compounds useful in the treatment of inflammatory diseases |